Related Topics

Phase I and II Clinical Trials

Recurrent Malignancies

Sema Jeha with a St. Jude patient
Why St. Jude for my child's participation in a Phase I or II clinical trial?
St. Jude has the ability to test different drugs on xenograft models in preclinical studies. In addition, St. Jude's pharmaceutical department can perform drug testing and analysis on site. Because St. Jude is a large referral center, it can conduct and run clinical trials effectively and in a timely manner. St. Jude's research and patient care are housed on the same campus, allowing scientists and clinicians to work together as a multidisciplinary team.
Phase I/II
Treatment using Phase I or II clinical trials
When a recurrence of cancer is diagnosed, treatment options may be limited. However, research is continually being done to improve cancer survival. Using clinical trials and medical research, tremendous advances have been made in the treatment of childhood cancer. Continued progress in the field of pediatric oncology depends upon identification and testing of experimental therapeutic agents in carefully conducted Phase I (1) and Phase II (2) trials.
Clinical Trials Explained
Clinical trials explained
Continued progress in the treatment and cure rates of childhood cancer depends on identifying and testing new drugs in carefully conducted clinical trials. New drugs and treatments are constantly being developed. Before any new drug can be evaluated in children, it has usually already been studied in the laboratory and on adults and has been deemed potentially safe for use in children. There are four levels of clinical trials.
Giles Robinson, MD, with a St. Jude patient
How to refer a patient for a Phase I or II clinical trial
To refer a patient to St. Jude for participation in a Phase I or II clinical trial, the child’s treating physician must contact a St. Jude physician.